Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned

Background: The current treatment landscape of early stage lung cancer is rapidly evolving, particularly in EGFR mutant non-small cell lung cancer (NSCLC), where target therapy is moving to early stages. In the current review, we collected the available data exploring the impact of EGFR targeting in...

Descripción completa

Detalles Bibliográficos
Autores principales: Belluomini, Lorenzo, Riva, Silvia Teresa, Simbolo, Michele, Nocini, Riccardo, Trestini, Ilaria, Avancini, Alice, Tregnago, Daniela, Ferrara, Miriam Grazia, Caldart, Alberto, Dodi, Alessandra, Caliò, Anna, Bria, Emilio, Scarpa, Aldo, Milella, Michele, Menis, Jessica, Pilotto, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535007/
https://www.ncbi.nlm.nih.gov/pubmed/34685665
http://dx.doi.org/10.3390/cells10102685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535007/
https://www.ncbi.nlm.nih.gov/pubmed/34685665
http://dx.doi.org/10.3390/cells10102685

Ejemplares similares